Filing Details
- Accession Number:
- 0001415889-24-029754
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-18 17:00:05
- Reporting Period:
- 2024-12-16
- Accepted Time:
- 2024-12-18 17:00:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1551152 | Abbvie Inc. | ABBV | Pharmaceutical Preparations (2834) | 320375147 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1968528 | K Kevin Buckbee | 1 N. Waukegan Road North Chicago IL 60064 | Svp, Controller | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2024-12-16 | 1,800 | $93.50 | 8,783 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2024-12-16 | 1,800 | $172.24 | 6,983 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to buy) | Disposition | 2024-12-16 | 1,800 | $93.50 | 1,800 | $93.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,111 | 2021-02-20 | 2030-02-19 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.